24 May 2013
Keywords: Sanofi, Genzyme, Aubagio, Australia, Multiple sclerosis
Article | 21 November 2012
Having already gained approval in the largest global pharma market, the USA, French drug major Sanofi’s (Euronext: SAN) ...
Enjoying this article? To continue reading you need to login or subscribe.
Subscriptions are £60 per month, pay as you go.
Find out more details.
21 November 2012
23 May 2013
© 2013 thepharmaletter.com